Senior Director, Clinical Diagnostics and Precision Medicine

Build Our Future Together Regeneron is seeking an accomplished companion diagnostics (CDx) leader to set strategy and drive execution across a portfolio of therapeutic programs and technologies. As Senior Director, you will ensure that diagnostic strategies are integrated early and aligned with clinical development, regulatory submission, launch readiness, and patient access objectives. You will lead a team of diagnostic professionals and are responsible for overall diagnostic (including CDx) strategies for the entire pipeline of therapeutic areas and across all technologies; partnering across Regeneron and with IVD partners to ensure diagnostic and therapeutic success. The role requires a leader who can translate biomarker hypotheses into fit-for-purpose diagnostic plans; guide assay selection, validation, and partner strategy; and influence across clinical, translational, regulatory, commercial, medical affairs, access, and external diagnostic organizations. When & where:  Location: Armonk, NY or Remote, USA Work model/flexibility: 4 days onsite or remote Discover your role:  Set and lead global companion diagnostics strategy across the entire pipeline and all technologies, integrating diagnostic plans with clinical strategy, clinical development objectives & timelines, regulatory requirements, launch planning, and patient identification needs. Translate biomarker biology, mechanism-of-action hypotheses, clinical utility considerations into diagnostic target product profiles across relevant platforms, including NGS, PCR, immunohistochemistry, immunoassays, and emerging technologies. Define assay selection and development strategy from feasibility through analytical and clinical validation, regulatory submission, and post-approval lifecycle planning. Lead a team to successfully develop diagnostic strategies that support patient selection (and relevant exploratory datasets), stratification, monitoring, and evidence generation, accounting for timelines, cost, tissue requirements, turnaround time, reimbursement, global regulations and regional implementation. Provide executive oversight of external IVD sponsors, laboratory, and technology partner relationships, including partner selection, contracting strategy, governance, budgets, and escalation of critical issues. Accountable for operational readiness of CDx testing in clinical trials, including study startup, laboratory workflows, sample management, data transfer, and quality oversight. Shape global CDx regulatory strategy in partnership with Regulatory Affairs, including FDA, EU IVDR, PMDA, and other regional requirements, performance study design, submission content, labeling, and health authority interactions. Serve as senior CDx subject matter expert and strategic advisor to program teams and leadership, influencing decisions across translational medicine, clinical development, regulatory, biostatistics, clinical operations, commercial, medical affairs, market access, quality, and legal by communicating complex considerations clearly and credibly. This role requires: Advanced degree (PhD, MD, MD/PhD, or equivalent) in molecular biology, pathology, translational medicine, oncology, biomedical engineering, diagnostics, or a related scientific discipline. 12 or more years of experience in companion diagnostics, IVD development, biomarker strategy, or translational medicine within pharma, biotech, or diagnostics, including progressive leadership responsibility. Demonstrated success leading CDx or biomarker-enabled diagnostic strategies through clinical development, regulatory submission, and therapeutic approval. Deep expertise in assay development, analytical and clinical validation, and clinical utility. Strong working knowledge of global CDx regulatory pathways, including FDA CDRH (PMA and supplemental submissions), EU IVDR, PMDA, performance studies, labeling, and post-approval obligations. Experience managing external diagnostic partners, IVD sponsors, central